Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies.  Astex is a member of the Otsuka group of pharmaceutical companies. The group also includes Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd and Taiho Oncology, Inc.  Subject to regulatory approvals, Astex's products will be commercialized in the US and Canada by Taiho subsidiaries, and the rest of the world by Otsuka subsidiaries.

Life Sciences

Pharmaceutical

Astex Pharmaceuticals, Inc. (US)

Harren Jhoti

John Lyons

Neil Jones

Michelle Jones

David Rees

The Leadership Team at Astex Pharmaceuticals, Inc. is responsible for guiding the strategic direction and overall vision of the company in the fight against cancer. This team, composed of executives from diverse areas including scientific research, drug discovery, clinical development, and corporate operations, collaborates to drive innovation, ensure regulatory compliance, and optimize resources, all while fostering partnerships within the Otsuka group and beyond. Their efforts are instrumental in advancing Astex's proprietary therapies from concept through commercialization.

Leadership Team

Research and Development

Clinical Operations

Leadership Team

About

Team members

Other teams at Astex Pharmaceuticals, Inc. (US)

Research and Development

Clinical Operations